Laura KanouseVining

Associate

Atlanta + 1.404.581.8352

Contact

Partager

Laura Kanouse Vining focuses her practice on biotechnology and pharmaceutical intellectual property litigation. Her experience includes representing clients in various U.S. district courts and before the International Trade Commission (ITC) and Patent Trial and Appeal Board (PTAB).

Laura leverages her technical background to defend and enforce clients' intellectual property rights in cutting-edge technology, including CRISPR (clustered regularly interspaced short palindromic repeats), proteomics, small molecule drugs, bioelectronics, and medical devices. Her litigation experience includes all phases of pretrial litigation. She has drafted motions, assisted with hearings, managed discovery, and deposed several fact witnesses. Laura also has worked extensively with expert witnesses, including assisting in drafting expert reports and preparing expert witnesses for depositions.

Laura is also deeply committed to pro bono work and community involvement. Currently, she is lead associate on a trial team seeking grant of asylum for a family of four as part of the Firm's Border Project. In addition, she serves on the Advisory Board for Georgia Lawyers for the Arts, a nonprofit organization that provides legal assistance and educational programming to artists and inventors.

Expérience

  • Venezuelan family obtains asylum for protection of political opinionJones Day obtained a grant of asylum for a Venezuelan family of three.
  • SHEnB resolves patent infringement claims brought at the ITC involving skin treatment devicesJones Day was lead counsel defending Sung Hwan E&B Co., Ltd. ("SHEnB"), a Korean manufacturer of medical devices for the health & beauty industry, and two of its distributors against patent infringement claims brought by Serendia, LLC before the International Trade Commission.
  • Ricoh resolves Lanham Act case involving its global "imagine. change." tagline in D. Minn.Jones Day defended Ricoh Co., Ltd. and Ricoh USA, Inc. in a Lanham Act case in the District of Minnesota in which a commercial printing company accused Ricoh of infringing certain trademarks owned by the plaintiff.
  • Specialty engineered woods manufacturer reaches settlement in trade secret and supply agreement disputeJones Day represented an industry leader in the manufacture of specialty engineered wood products in a lawsuit against a supplier involving allegations of misappropriation of trade secrets, breach of contract, tortious interference, and unfair competition.
  • ToolGen faces off in two patent interferences involving CRISPR/Cas9 applicationJones Day is representing ToolGen, Inc. in two patent interferences involving CRISPR/Cas9 technology.
    •

    February 2022 Commentary

    Tillis Urges FDA, USPTO to Investigate Potential False Narrative by Drug Critics

    December 2021 White Paper

    Navigating Trade Secret Identification During Discovery: Timing & Scope

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.